Related Experiment Video
Updated: Nov 2, 2025
Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
Laryngeal squamous cell carcinoma cell lines show high tolerance for siRNA-mediated CDK1 knockdown
Kinga Bednarek1, Magdalena Kostrzewska-Poczekaj1, Adam Ustaszewski1
1Institute of Human Genetics, Polish Academy of Sciences Poznan, Poland.
Abstract:
Alterations of the cell cycle checkpoints lead to uncontrolled cell growth and result in tumorigenesis. One of the genes essential for cell proliferation and cell cycle regulation is CDK1. This makes it a potential target in cancer therapy. In our previous study we have shown upregulation of this gene in laryngeal squamous cell carcinoma (LSCC). Here we analyze the impact of siRNA-mediated CDK1 knockdown on cell proliferation and viability, measured with cell growth monitoring and colorimetric test (CCK8 assay), respectively. We proved that a reduction of CDK1 expression by more than 50% has no effect on these cellular processes in LSCC cell lines (n=2). Moreover, using microarrays, we analyzed global gene expression deregulation in these cell lines after CDK1 knockdown. We searched for enriched ontologies in the group of identified 137 differentially expressed genes (>2-fold change). Within this group we found 3 enriched pathways: protein binding (GO:0005515), mitotic nuclear division (GO:0007067) and transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169) and a group of 11 genes encoding proteins for which interaction with CDK1 was indicated with the use of bioinformatic tools. Among these genes we propose three: CDK6, CALD1 and FYN as potentially dependent on CDK1.
Insights
Reducing CDK1 gene expression did not affect cell proliferation or viability in laryngeal squamous cell carcinoma (LSCC) cell lines. Gene expression analysis revealed potential CDK1-dependent genes, including CDK6, CALD1, and FYN.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Cell cycle checkpoint alterations drive uncontrolled cell growth and tumorigenesis.
- Cyclin-dependent kinase 1 (CDK1) is crucial for cell proliferation and cell cycle regulation, making it a potential cancer therapy target.
- Previous studies indicated CDK1 upregulation in laryngeal squamous cell carcinoma (LSCC).
Purpose of the Study:
- To investigate the impact of siRNA-mediated CDK1 knockdown on LSCC cell proliferation and viability.
- To analyze global gene expression changes following CDK1 knockdown in LSCC cell lines.
- To identify potential downstream targets of CDK1 in LSCC.
Main Methods:
- siRNA-mediated knockdown of CDK1 in LSCC cell lines.
- Cell proliferation and viability assessed using cell growth monitoring and CCK8 assay.
- Global gene expression profiling via microarrays, followed by bioinformatics analysis of differentially expressed genes and enriched pathways.
Main Results:
- A reduction in CDK1 expression by over 50% did not significantly affect LSCC cell proliferation or viability.
- Microarray analysis identified 137 differentially expressed genes (>2-fold change) post-CDK1 knockdown.
- Enriched pathways included protein binding, mitotic nuclear division, and transmembrane receptor protein tyrosine kinase signaling. Three genes (CDK6, CALD1, FYN) were identified as potentially CDK1-dependent.
Conclusions:
- CDK1 knockdown alone does not inhibit proliferation or viability in LSCC cell lines.
- Gene expression analysis provides insights into cellular pathways affected by CDK1 modulation.
- CDK6, CALD1, and FYN are proposed as potential novel CDK1 targets in LSCC, warranting further investigation.
